Please select the option that best describes you:

For an otherwise healthy post-menopausal woman with early stage HR+ BC and persistent AI intolerance, is there an age cutoff above which you would consider avoiding adjuvant tamoxifen therapy?  

The patient has an intact uterus and has failed all available AI therapies due to multiple intolerances. 



Answer from: Medical Oncologist at Academic Institution
Sign in or Register to read more